Co-Pay Relief Program Announces Assistance for Two New Disease Areas, Spinal Muscular Atrophy and Hepatocellular Carcinoma

PAF’s Co-Pay Relief (CPR) program is pleased to announce that assistance will now be available to patients with spinal muscular atrophy and hepatocellular carcinoma through the launch of two new disease funds that can provide direct payment for co-payments, co-insurance and deductibles required by the patient’s insurer for medications prescribed to treat and manage their disease.

The Co-Pay Relief Program may help with all therapeutic and supportive medications, including generic or bioequivalent products prescribed to treat and/or manage the patient’s disease or condition. The program helps patients on a first-come, first-serve basis and processes applicants in the order in which their completed applications are received. To learn more about the spinal muscular atrophy and hepatocellular carcinoma funds, including specific eligibility criteria, please visit

To apply for assistance please visit, with access available for patients, providers and pharmacies, or connect with our team via phone at 866-512-3861.